Cited by 627Migraine and Headache StudiesMusculoskeletal pain and rehabilitationTraumatic Brain Injury Research

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

Blumenfeld, AM, Varon, SF, Wilcox, TK, Buse, DC, Kawata, AK, Manack, A, Goadsby, PJ, Lipton, RB·2011·Cephalalgia

Open this paper in CoChat — free account

Abstract

Background: Migraine imposes significant burden on patients, their families and health care systems. In this study, we compared episodic to chronic migraine sufferers to determine if migraine status predicted headache-related disability, health-related quality of life (HRQoL) and health care resource utilization. Methods: A Web-based survey was administered to panelists from nine countries. Participants were classified as having chronic migraine (CM), episodic migraine (EM) or neither using a validated questionnaire. Data collected and then analyzed included sociodemographics, clinical characteristics, Migraine Disability Assessment, Migraine-Specific Quality of Life v2.1, Patient Health Questionnaire and health care resource utilization. Findings: Of the respondents, 5.7% had CM and 94.3% had EM, with CM patients reporting significantly more severe disability, lower HRQoL, higher levels of anxiety and depression and greater health care resource utilization compared to those with EM. Interpretation: These results provide evidence that will enhance our understanding of the factors driving health care costs and will contribute to development of cost-effective health care strategies.

Integrity signals

Registry

Crossref · 10.1177/0333102410381145

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766
An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ–4
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2009) · Psychosomatics · doi:10.1016/s0033-3182(09)70864-3 · Cited by 4,261
The global burden of headache: A documentation of headache prevalence and disability worldwide
Stovner, L., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A., Steiner, T., & Zwart, J.-A. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01288.x · Cited by 2,444
Self-citation
Migraine prevalence, disease burden, and the need for preventive therapy
Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007) · Neurology · doi:10.1212/01.wnl.0000252808.97649.21 · Cited by 2,337
Self-citation
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
Self-citation
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
Stewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001) · Neurology · doi:10.1212/wnl.56.suppl_1.s20 · Cited by 1,210
Self-citation
The Global Burden of Disease Study
Menken, M., Munsat, T. L., & Toole, J. F. (2000) · Archives of Neurology · doi:10.1001/archneur.57.3.418 · Cited by 1,059

Flagged first, then by citations

Show all 50 references

1 of the 50 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

Harwood RH, 2004, Bull World Health Organ, 82, 251
Hung PH, 2006, Acta Neurol Taiwan, 15, 43
Kroenke K, 2009, Psychosomatics, 50, 613
Stewart WF, 1994, Neurology, 44, S24

Sorted by citations

Items 101–200 of 626

Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study
Wang, S., Roxas, A., Saravia, B., Kim, B., Chowdhury, D., Riachi, N. J., Tai, M. S., Tanprawate, S., Ngoc, T. T., Zhao, Y. J., et al. (2021) · Cephalalgia · doi:10.1177/03331024211024160 · Cited by 65
Altered cognition-related brain activity and interactions with acute pain in migraine
Mathur, V. A., Khan, S. A., Keaser, M. L., Hubbard, C. S., Goyal, M., & Seminowicz, D. A. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.01.003 · Cited by 67
Risk Factors of Chronic Daily Headache or Chronic Migraine
Cho, S., & Chu, M. K. (2014) · Current Pain and Headache Reports · doi:10.1007/s11916-014-0465-9 · Cited by 66
The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK
Batty, A. J., Hansen, R. N., Bloudek, L. M., Varon, S. F., Hayward, E., Pennington, B., Lipton, R. B., & Sullivan, S. D. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.802694 · Cited by 66
Self-citation
Migraine – more than a headache: women’s experiences of living with migraine
Rutberg, S., & Öhrling, K. (2011) · Disability and Rehabilitation · doi:10.3109/09638288.2011.607211 · Cited by 64
Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting
Kollewe, K., Escher, C. M., Wulff, D. U., Fathi, D., Paracka, L., Mohammadi, B., Karst, M., & Dressler, D. W. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1539-0 · Cited by 63
Long‐Term Efficacy of a Double‐Blind, Placebo‐Controlled, Randomized Study for Repetitive Sphenopalatine Blockade With Bupivacaine vs Saline With the Tx 360 ® Device for Treatment of Chronic Migraine
Cady, R. K., Saper, J. R., Dexter, K., Cady, R. J., & Manley, H. R. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12546 · Cited by 63
Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series
Lauritsen, C. G., Mazuera, S., Lipton, R. B., & Ashina, S. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0700-3 · Cited by 62
Self-citation
Chemical Intolerance in Primary Care Settings: Prevalence, Comorbidity, and Outcomes
Katerndahl, D. A., Bell, I. R., Palmer, R. F., & Miller, C. S. (2012) · The Annals of Family Medicine · doi:10.1370/afm.1346 · Cited by 61
High Frequency Migraine Is Associated with Lower Acute Pain Sensitivity and Abnormal Insula Activity Related to Migraine Pain Intensity, Attack Frequency, and Pain Catastrophizing
Mathur, V. A., Moayedi, M., Keaser, M. L., Khan, S. A., Hubbard, C. S., Goyal, M., & Seminowicz, D. A. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00489 · Cited by 58
Behavioral Interventions for Migraine
Pérez-Muñoz, A., Buse, D. C., & Andrasik, F. (2019) · Neurologic Clinics · doi:10.1016/j.ncl.2019.07.003 · Cited by 58
Self-citation
Migraine diagnosis: Screening items, instruments, and scales
Peng, K.-P., & Wang, S.-J. (2012) · Acta Anaesthesiologica Taiwanica · doi:10.1016/j.aat.2012.05.002 · Cited by 59
Quality of Life and Migraine Disability among Female Migraine Patients in a Tertiary Hospital in Malaysia
Shaik, M. M., Hassan, N. B., Tan, H. L., & Gan, S. H. (2015) · BioMed Research International · doi:10.1155/2015/523717 · Cited by 58
Migraine treatment and healthcare costs: retrospective analysis of the China Health Insurance Research Association (CHIRA) database
Yu, S., Zhang, Y., Yao, Y., & Cao, H. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01117-2 · Cited by 56
Migraine in the workplace
de Dhaem, O. B., & Sakai, F. (2022) · eNeurologicalSci · doi:10.1016/j.ensci.2022.100408 · Cited by 56
Association Between Dietary Iron Intake and Serum Ferritin and Severe Headache or Migraine
Meng, S., Zhou, H., Li, X., Wang, M., Kang, L., Fu, J., Li, X., Li, X., & Zhao, Y. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.685564 · Cited by 55
Development of onabotulinumtoxinA for chronic migraine
Whitcup, S. M., Turkel, C. C., DeGryse, R. E., & Brin, M. F. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12488 · Cited by 55
No Microstructural White Matter Alterations in Chronic and Episodic Migraineurs: A Case–Control Diffusion Tensor Magnetic Resonance Imaging Study
Neeb, L., Bastian, K., Villringer, K., Gits, H. C., Israel, H., Reuter, U., & Fiebach, J. B. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12496 · Cited by 55
Psychopathological comorbidities in medication‐overuse headache: a multicentre clinical study
Sarchielli, P., Corbelli, I., Messina, P., Cupini, L. M., Bernardi, G., Bono, G., Piero, V. D., Petolicchio, B., Livrea, P., Prudenzano, M. P., et al. (2015) · European Journal of Neurology · doi:10.1111/ene.12794 · Cited by 54
Headache characteristics and burden from chronic migraine with medication overuse headache: Cross‐sectional observations from the Medication Overuse Treatment Strategy trial
Schwedt, T. J., Hentz, J. G., Sahai‐Srivastava, S., Spare, N. M., Martin, V. T., Treppendahl, C., Digre, K. B., Bennett, N. L., Birlea, M., Watson, D., et al. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14056 · Cited by 54
Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort
Waliszewska‐Prosół, M., Straburzyński, M., Czapińska-Ciepiela, E., Nowaczewska, M., Gryglas‐Dworak, A., & Budrewicz, S. P. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01575-4 · Cited by 54
Serum Homocysteine, Pyridoxine, Folate, and Vitamin B12 Levels in Migraine: Systematic Review and Meta‐Analysis
Liampas, I., Siokas, V., Mentis, A. A., Aloizou, A., Dastamani, M., Tsouris, Z., Aslanidou, P., Brotis, A. G., & Dardiotis, E. (2020) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13892 · Cited by 55
Neural Plasticity in Common Forms of Chronic Headaches
Lai, T., Protsenko, E., Cheng, Y.-C., Loggia, M. L., Coppola, G., & Chen, W. (2015) · Neural Plasticity · doi:10.1155/2015/205985 · Cited by 53
Acute Treatment Optimization in Episodic and Chronic Migraine: Results of the A merican M igraine P revalence and P revention ( AMPP ) Study
Serrano, D., Buse, D. C., Adams, A. M., Reed, M. L., & Lipton, R. B. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12553 · Cited by 53
Self-citation
Prevalence of primary headache disorders in Fayoum Governorate, Egypt
El-Sherbiny, N. A., Masoud, M., Shalaby, N., & Shehata, H. (2015) · The Journal of Headache and Pain · doi:10.1186/s10194-015-0569-6 · Cited by 52
Persistent Frequent Nausea Is Associated With Progression to Chronic Migraine: AMPP Study Results
Reed, M. L., Fanning, K. M., Serrano, D., Buse, D. C., & Lipton, R. B. (2014) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12450 · Cited by 52
Self-citation
Prevalence, management and burden of episodic and chronic headaches—a cross-sectional multicentre study in eight Austrian headache centres
Zebenholzer, K., Andree, C., Lechner, A., Broessner, G., Lampl, C., Luthringshausen, G., Wuschitz, A., Obmann, S.-M., Berek, K., & Wöber, C. (2015) · The Journal of Headache and Pain · doi:10.1186/s10194-015-0531-7 · Cited by 50
Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine
Buse, D. C., Yugrakh, M. S., Lee, L. K., Bell, J., Cohen, J. M., & Lipton, R. B. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.20100 · Cited by 50
Self-citation
United States Patients’ Perspective of Living With Migraine: Country‐Specific Results From the Global “My Migraine Voice” Survey
Gibbs, S. N., Shah, S., Deshpande, C. G., Bensink, M. E., Broder, M. S., Dumas, P. K., Buse, D. C., Vo, P., & Schwedt, T. J. (2020) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13829 · Cited by 50
Self-citation
Migraine Headaches and Mood/Anxiety Disorders in the ELSA B razil
Goulart, A. C., Santos, I. S., Brunoni, A. R., Nunes, M. A., Passos, V. M. D. A., Griep, R. H., Lotufo, P. A., & Benseñor, I. M. (2014) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12397 · Cited by 51
Treatment of Chronic Migraine
Diener, H., Holle, D., & Dodick, D. W. (2010) · Current Pain and Headache Reports · doi:10.1007/s11916-010-0159-x · Cited by 51
Global perspectives on the burden of episodic and chronic migraine
Buse, D. C., & Lipton, R. B. (2013) · Cephalalgia · doi:10.1177/0333102413477736 · Cited by 51
Self-citation
Migraine: Advances in the Pathogenesis and Treatment
Pleș, H., Florian, I. A., Timiș, T. L., Covache-Busuioc, R.-A., Glavan, L.-A., Dumitrascu, D.-I., Popa, A. A., Bordeianu, A., & Ciurea, A. V. (2023) · Neurology International · doi:10.3390/neurolint15030067 · Cited by 50
Treatment Update of Chronic Migraine
Cho, S., Song, T., & Chu, M. K. (2017) · Current Pain and Headache Reports · doi:10.1007/s11916-017-0628-6 · Cited by 52
Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials
Silberstein, S. D., McAllister, P., Ning, X., Faulhaber, N., Lang, N., Yeung, P. P., Schiemann, J., Aycardi, E., Cohen, J. M., Janka, L., et al. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13534 · Cited by 50
The Humanistic and Economic Burden of Migraine in Europe: A Cross-Sectional Survey in Five Countries
Doane, M. J., Gupta, S., Fang, J., Laflamme, A. K., & Vo, P. G. (2020) · Neurology and Therapy · doi:10.1007/s40120-020-00196-2 · Cited by 50
Pearls and pitfalls: Neurostimulation in headache
Jürgens, T. P., & Leone, M. (2013) · Cephalalgia · doi:10.1177/0333102413483933 · Cited by 49
Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial
Shehata, H., Esmail, E., Abdelalim, A., El-Jaafary, S. I., Elmazny, A. N., Sabbah, A., & Shalaby, N. (2016) · Journal of Pain Research · doi:10.2147/jpr.s116671 · Cited by 50
Efficacy and mechanism of anticonvulsant drugs in migraine
Hoffmann, J., Akerman, S., & Goadsby, P. J. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.885835 · Cited by 48
Self-citation
Treatment Persistence and Switching in Triptan Users: A Systematic Literature Review
Messali, A. J., Yang, M., Gillard, P. J., Tsai, K., Tepper, S. J., Bloudek, L. M., & Kori, S. H. (2014) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12404 · Cited by 48
Exercise in Treatment of Migraine Including Chronic Migraine
Song, T.-J., & Chu, M. (2021) · Current Pain and Headache Reports · doi:10.1007/s11916-020-00929-w · Cited by 41
Associations Between Headache-Free Days and Patient-Reported Outcomes Among Migraine Patients: A Cross-Sectional Analysis of Survey Data in Europe
Doane, M. J., Gupta, S., Vo, P. G., Laflamme, A. K., & Fang, J. (2019) · Pain and Therapy · doi:10.1007/s40122-019-0133-1 · Cited by 46
Complementary and Conventional Medicine Use Among Youth With Recurrent Headaches
Bethell, C. D., Kemper, K. J., Gombojav, N., & Koch, T. (2013) · PEDIATRICS · doi:10.1542/peds.2013-1816 · Cited by 47
The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis
Matharu, M. S., Halker, R. B., Pozo‐Rosich, P., DeGryse, R. E., Adams, A. M., & Aurora, S. K. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0784-4 · Cited by 47
In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study
Alpuente, A., Gallardo, V. J., Caronna, E., Torres‐Ferrús, M., & Pozo‐Rosich, P. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01366-9 · Cited by 47
Real‐World Economic Impact of Onabotulinumtoxin A in Patients With Chronic Migraine
Rothrock, J. F., Bloudek, L. M., Houle, T. T., Andress‐Rothrock, D., & Varon, S. F. (2014) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12456 · Cited by 47
Self-citation
Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID)
Hareendran, A., Mannix, S., Skalicky, A. M., Bayliss, M. S., Blumenfeld, A. M., Buse, D. C., Desai, P. R., Ortmeier, B. G., & Sapra, S. J. (2017) · Health and Quality of Life Outcomes · doi:10.1186/s12955-017-0799-1 · Cited by 45
Self-citation
Mapping from Disease-Specific Measures to Health-State Utility Values in Individuals with Migraine
Gillard, P. J., Devine, B., Varon, S. F., Liu, L., & Sullivan, S. D. (2012) · Value in Health · doi:10.1016/j.jval.2011.12.007 · Cited by 47
Self-citation
Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society
Diener, H., Ashina, M., Durand‐Zaleski, I., Kurth, T., Lantéri‐Minet, M., Lipton, R. B., Ollendorf, D. A., Pozo‐Rosich, P., Tassorelli, C., & Terwindt, G. M. (2021) · Cephalalgia · doi:10.1177/0333102421989247 · Cited by 45
Self-citation
Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study
Pozo‐Rosich, P., Lucas, C., Watson, D. P. B., Gaul, C., Ramsden, E., Ritter, S., Martelletti, P., & Snellman, J. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00331-3 · Cited by 45
Neurobiology of migraine progression
Rattanawong, W., Rapoport, A. M., & Srikiatkhachorn, A. (2022) · Neurobiology of Pain · doi:10.1016/j.ynpai.2022.100094 · Cited by 46
Headache-related health resource utilisation in chronic and episodic migraine across six countries
Sanderson, J. C., Devine, E. B., Lipton, R. B., Bloudek, L. M., Varon, S. F., Blumenfeld, A. M., Goadsby, P. J., Buse, D. C., & Sullivan, S. D. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305197 · Cited by 45
Self-citation
Update on the Pharmacological Treatment of Chronic Migraine
Sun‐Edelstein, C., & Rapoport, A. M. (2016) · Current Pain and Headache Reports · doi:10.1007/s11916-015-0533-9 · Cited by 45
Response Predictors in Chronic Migraine: Medication Overuse and Depressive Symptoms Negatively Impact Onabotulinumtoxin-A Treatment
di Cola, F. S., Caratozzolo, S., Liberini, P., Rao, R., & Padovani, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00678 · Cited by 45
Pyridoxine, folate and cobalamin for migraine: A systematic review
Liampas, I., Siokas, V., Aloizou, A., Tsouris, Z., Dastamani, M., Aslanidou, P., Brotis, A. G., & Dardiotis, E. (2020) · Acta Neurologica Scandinavica · doi:10.1111/ane.13251 · Cited by 45
Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)
Johnston, K., Harris, L. A., Powell, L. C., Popoff, E., Coric, V., L'Italien, G. J., & Schreiber, C. P. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01378-5 · Cited by 44
Acute sleep deprivation enhances susceptibility to the migraine substrate cortical spreading depolarization
Negro, A., Seidel, J. L., Houben, T., Yu, E. S., Rosen, I., Arreguin, A. J., Yalcin, N., Shorser-Gentile, L., Pearlman, L., Sadhegian, H., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01155-w · Cited by 45
Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale
Lipton, R. B., Buse, D. C., Adams, A. M., Varon, S. F., Fanning, K. M., & Reed, M. L. (2017) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13028 · Cited by 43
Self-citation
Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials
Porter, J. K., Tanna, G. L. D., Lipton, R. B., Sapra, S. J., & Villa, G. (2018) · PharmacoEconomics - Open · doi:10.1007/s41669-018-0105-0 · Cited by 43
Self-citation
Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care
Korolainen, M. A., Kurki, S. H., Lassenius, M. I., Toppila, I., Costa‐Scharplatz, M., Purmonen, T. T., & Nissilä, M. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0964-5 · Cited by 42
Migraine and Despair: Factors Associated with Depression and Suicidal Ideation among Canadian Migraineurs in a Population-Based Study
Fuller‐Thomson, E., Schrumm, M., & Brennenstuhl, S. (2013) · Depression Research and Treatment · doi:10.1155/2013/401487 · Cited by 42
Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database
Hepp, Z., Rosen, N. L., Gillard, P. G., Varon, S. F., Mathew, N., & Dodick, D. W. (2015) · Cephalalgia · doi:10.1177/0333102415621294 · Cited by 42
Self-citation
Operational Diagnostic Criteria for Chronic Migraine: Expert Opinion
Silberstein, S. D., Lipton, R. B., & Dodick, D. W. (2014) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12407 · Cited by 41
Self-citation
Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure
Ruff, D. D., Ford, J. H., Tockhorn‐Heidenreich, A., Sexson, M., Govindan, S., Pearlman, E. M., Wang, S., Khan, A., & Aurora, S. K. (2019) · Cephalalgia · doi:10.1177/0333102419847957 · Cited by 41
Migraine patients’ journey until a tertiary headache center: an observational study
Peres, M. F. P., Swerts, D. B., Oliveira, A. B., & Silva‐Néto, R. P. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1039-3 · Cited by 42
Effect of fremanezumab on quality of life and productivity in patients with chronic migraine
Lipton, R. B., Cohen, J. M., Gandhi, S. K., Yang, R., Yeung, P. P., & Buse, D. C. (2020) · Neurology · doi:10.1212/wnl.0000000000010000 · Cited by 41
Self-citation
Difficulties in work activities and the pervasive effect over disability in patients with episodic and chronic migraine
D’Amico, D., Grazzi, L., Curone, M., Fiore, P. D., Cecchini, A. P., Leonardi, M., Scaratti, C., & Raggi, A. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2130-4 · Cited by 41
Estimating the savings associated with a migraine‐free life: results from the Spanish Atlas
Irimia, P., Garrido‐Cumbrera, M., Lasaosa, S. S., Braçe, O., Colomina, I., Mur, C. B., & Pozo‐Rosich, P. (2020) · European Journal of Neurology · doi:10.1111/ene.14431 · Cited by 39
Treating Chronic Migraine With Neuromodulation: The Role of Neurophysiological Abnormalities and Maladaptive Plasticity
Viganò, A., Toscano, M., Puledda, F., & Piero, V. D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00032 · Cited by 42
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
Nierenburg, H., Vieira, J. R., Lev, N., Lin, T., Harris, D., Vizel, M., Ironi, A., Lewis, B. L., & Wright, P. (2020) · Pain and Therapy · doi:10.1007/s40122-020-00185-1 · Cited by 39
Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial
Reuter, U., Lucas, C., Doležil, D., Hand, A. L., Port, M. D., Nichols, R., Stroud, C., Tockhorn‐Heidenreich, A., & Detke, H. C. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01911-7 · Cited by 39
Early Use of Erenumab vs Nonspecific Oral Migraine Preventives
Pozo‐Rosich, P., Doležil, D., Paemeleire, K., Stępień, A., Stude, P., Snellman, J., Arkuszewski, M., Stites, T. E., Ritter, S., López, C. L., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.0368 · Cited by 41
Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study
Winner, P. K., Blumenfeld, A. M., Eross, E. J., Orejudos, A. C., Mirjah, D. L., Adams, A. M., & Brin, M. F. (2019) · Drug Safety · doi:10.1007/s40264-019-00824-3 · Cited by 38
Self-citation
OnabotulinumtoxinA (BOTOX®)
Frampton, J. E. (2012) · Drugs · doi:10.2165/11208880-000000000-00000 · Cited by 37
Best Practices for Patients With Chronic Migraine
Starling, A. J., & Dodick, D. W. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.01.010 · Cited by 37
Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials
Ruff, D. D., Ford, J. H., Tockhorn‐Heidenreich, A., Stauffer, V. L., Govindan, S., Aurora, S. K., Terwindt, G. M., & Goadsby, P. J. (2019) · European Journal of Neurology · doi:10.1111/ene.14114 · Cited by 37
Self-citation
Health-related quality of life in tension-type headache: a population-based study
Ashina, S., Buse, D. C., Bjørner, J. B., Bendtsen, L., Lyngberg, A. C., Jensen, R., & Lipton, R. B. (2021) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2020-0166 · Cited by 37
Self-citation
Tackling chronic migraine: current perspectives
Carod-Artal, F. J. (2014) · Journal of Pain Research · doi:10.2147/jpr.s61819 · Cited by 36
Emerging drugs for migraine treatment
Giamberardino, M. A., & Martelletti, P. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.999040 · Cited by 37
Economic burden of migraine in Latvia and Lithuania: direct and indirect costs
Lublóy, Á. (2019) · BMC Public Health · doi:10.1186/s12889-019-7461-2 · Cited by 35
Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway
Hedblom, A. H., Axelsson, I., Jacobson, L. K., Tedroff, J., & Borgström, F. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01162-x · Cited by 36
No “Wearing‐Off Effect” Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long‐Term Study
Blumenfeld, A. M., Stevanović, D., Ortega, M., Cohen, J. M., Seminerio, M. J., Yang, R., Jiang, B., & Tepper, S. J. (2020) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13994 · Cited by 36
Self-citation
Hypersensitivity to calcitonin gene-related peptide in chronic migraine
Iljazi, A., Ashina, H., Zhuang, Z. A., López, C. L., Snellman, J., Ashina, M., & Schytz, H. W. (2020) · Cephalalgia · doi:10.1177/0333102420981666 · Cited by 36
Widespread mechanical pain hypersensitivity in patients with chronic migraine and temporomandibular disorders: relationship and correlation between psychological and sensorimotor variables
Garrigós-Pedrón, M., Touche, R. L., Navarro-Desentre, P., Gracia-Naya, M., & Segura‐Ortí, E. (2019) · Acta Odontologica Scandinavica · doi:10.1080/00016357.2018.1538533 · Cited by 36
Characterization of Acute Prescription Migraine Medication Use
Hutchinson, S. L., Lipton, R. B., Ailani, J., Reed, M. L., Fanning, K. M., Adams, A. M., & Buse, D. C. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.11.025 · Cited by 35
Self-citation
Insomnia in probable migraine: a population-based study
Kim, J., Cho, S., Kim, W., Yang, K. I., Yun, C., & Chu, M. K. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0681-2 · Cited by 35
Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: A six-month follow-up of the COMOESTAS Project
Bottiroli, S., Allena, M., Sances, G., Icco, R. D., Avenali, M., Fadić, R., Katsarava, Z., Láinez, M. J. A., Goicochea, M. T., Bendtsen, L., et al. (2018) · Cephalalgia · doi:10.1177/0333102418783317 · Cited by 34
Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ)
Kawata, A. K., Hareendran, A., Shaffer, S., Mannix, S., Thach, A., Desai, P., Mikol, D. D., Ortmeier, B. G., Bayliss, M. S., & Buse, D. C. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13569 · Cited by 33
Self-citation
Acute treatment patterns in patients with migraine newly initiating a triptan
Lipton, R. B., Marcus, S. C., Shewale, A. R., Dodick, D. W., Viswanathan, H. N., & Doshi, J. A. (2020) · Cephalalgia · doi:10.1177/0333102420905307 · Cited by 34
Self-citation
The socioeconomic burden of migraine: An evaluation of productivity losses due to migraine headaches based on a population study in Germany
Seddik, A. H., Branner, J. C., Ostwald, D. A., Schramm, S. H., Bierbaum, M., & Katsarava, Z. (2020) · Cephalalgia · doi:10.1177/0333102420944842 · Cited by 34
Correlation of Headache Frequency and Psychosocial Impairment in Migraine: A Cross‐Sectional Study
Ruscheweyh, R., Muller, M. L., Blum, B., & Straube, A. (2013) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12195 · Cited by 33
Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse
Ahmed, F., Zafar, H., Buture, A., & Khalil, M. (2015) · SpringerPlus · doi:10.1186/s40064-015-1386-8 · Cited by 33
Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life
Tassorelli, C., Tedeschi, G., Sarchielli, P., Pini, L. A., Grazzi, L., Geppetti, P., de Tommaso, M., Aguggia, M., Cortelli, P., & Martelletti, P. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1419867 · Cited by 33
Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study
Stark, C., Stark, R. J., Limberg, N., Rodrigues, J. P., Cordato, D. J., Schwartz, R., & Jukic, R. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1030-z · Cited by 33
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study
Yu, S., Kim, B., Wang, H., Zhou, J., Wan, Q., Yu, T., Lian, Y., Arkuszewski, M., Ecochard, L., Wen, S., et al. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01514-9 · Cited by 33
OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study
Aydınlar, E. I., Dikmen, P. Y., Kosak, S., & Kocaman, A. S. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0723-4 · Cited by 33
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
Vikelis, M., Argyriou, A. A., Dermitzakis, E. V., Spingos, K. C., & Mitsikostas, D. D. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0676-z · Cited by 32
Episodic and Chronic Migraine in Primary Care
Young, N. P., Philpot, L. M., Vierkant, R. A., Rosedahl, J. K., Upadhyaya, S. G., Harris, A., & Ebbert, J. O. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13543 · Cited by 32
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension
Lipton, R. B., Tepper, S. J., Silberstein, S. D., Kudrow, D., Ashina, M., Reuter, U., Dodick, D. W., Zhang, F., Rippon, G. A., Cheng, S., et al. (2020) · Cephalalgia · doi:10.1177/0333102420973994 · Cited by 32
Self-citation
Human Milk and Plasma Pharmacokinetics of Single-Dose Rimegepant 75 mg in Healthy Lactating Women
Baker, T. E., Croop, R., Kamen, L., Price, P., Stock, D. A., Ivans, A., Bhardwaj, R., Anderson, M. S., Madonia, J., Stringfellow, J., et al. (2022) · Breastfeeding Medicine · doi:10.1089/bfm.2021.0250 · Cited by 32

Authors: Blumenfeld, A., Varon, S., Wilcox, T., Buse, D., Kawata, A., Manack, A., Goadsby, P., & Lipton, R.
Affiliations: The Neurology Center, USA.
Allergan (United States) (US)
United BioSource Corporation, USA.
Albert Einstein College of Medicine (US)
University of California, USA.
Montefiore Headache Center and Albert Einstein College of Medicine, USA.
Corresponding author: Blumenfeld, AM
Venue: Cephalalgia
Publisher: SAGE Publications
Published: 2010-09-02
Volume: 31
Issue: 3
Pages: 301-315
ISSN: 0333-1024 (ISSN-L)
1468-2982
DOI: 10.1177/0333102410381145
OpenAlex: W2142670324
Cited by: 627
References: 50
Citations by year: 2026: 22 · 2025: 34 · 2024: 53 · 2023: 50 · 2022: 41 · 2021: 58 · 2020: 79 · 2019: 49 · 2018: 39 · 2017: 25 · 2016: 34 · 2015: 38 · 2014: 26 · 2013: 27 · 2012: 38
FWCI: 16.79
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Cephalalgia (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
Keywords: chronic migraine, episodic migraine, headache-related disability, health-related quality of life, healthcare resource utilization, anxiety, depression, health care costs
MeSH terms: Adult, Chronic Disease, Cross-Sectional Studies, Data Collection, Disability Evaluation, Female, Health Resources, Humans, Male, Migraine Disorders, Online Systems, Quality of Life, Cost of Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks